Gabriela Zurek

Title: Gabriela Zurek: Innovator in Diagnostic Markers

Introduction

Gabriela Zurek is a prominent inventor based in Muenster, Germany. She has made significant contributions to the field of medical diagnostics, particularly in the regulation of cytochrome P450 metabolism of unsaturated fatty acids. Her work has the potential to impact patient care and diagnosis in various medical conditions.

Latest Patents

Gabriela Zurek holds a patent for her invention titled "Linoleic acid diol and glucuronide conjugate levels as diagnostic markers of disorders of abnormal regulation of cytochrome P450 metabolism of unsaturated fatty acids." This invention provides methods for using dihydroxy unsaturated fatty acids as markers to identify patients with disorders associated with abnormal regulation of cytochrome P450 metabolism. For instance, linoleic acid diols, including leukotoxindiol, can serve as diagnostic tools for identifying patients with pre-eclampsia, eclampsia, and pregnancy-induced hypertension. She has 1 patent to her name.

Career Highlights

Gabriela Zurek is affiliated with the University of California, where she continues her research and innovation in the field of medical diagnostics. Her work is recognized for its potential to enhance the understanding and treatment of various health conditions.

Collaborations

Gabriela has collaborated with notable colleagues, including John Newman and Shirley Gee, to advance her research and develop innovative diagnostic methods.

Conclusion

Gabriela Zurek's contributions to the field of diagnostics highlight her role as an innovator in medical research. Her patented methods for identifying disorders through fatty acid metabolism represent a significant advancement in patient diagnosis and care.